Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: Preliminary report

Urology

Volumn 54, Issue 3, 1999, Pages 486-489

  Terris, Martha K ^a,b  

^a Section of Urology   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RECTUM; SURGICAL TECHNIQUE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0032838888     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00148-X     Document Type: Article

References (30)

1. Hodge KK, McNeal JE, Terris MK, et al: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-75, 1989.
2. Amling CL, Blute ML, Lerner SE, et al: Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc 73: 401-406, 1998.
3. Stephenson RA, and Stanford JL: Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol 15: 331-335, 1997.
4. Gilliland FD, Hunt WC, and Key CR: Improving survival for patients with prostate cancer diagnosis in the prostate-specific antigen era. Urology 48: 67-71, 1996.
5. Farkas A, Schnieder D, Perrotti M, et al: National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate specific antigen screening. Urology 52: 444-449, 1998.
6. Norberg M, Egevad L, Holmberg L, et al: The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50: 562-566, 1997.
7. Levine MA, Ittman M, Melamed J, et al: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159: 471-476, 1998.
8. Keetch DW, Catalona WJ, and Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen levels. J Urol 151: 1572-1574, 1994.
9. Ellis WJ, and Brawer MK: Repeat prostate needle biopsy: who needs it? J Urol 153: 1496-1498, 1995.
10. Roehrborn CG, Pickens GJ, and Sanders JS: Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnosis and prostate-specific antigen levels. Urology 47: 347-352, 1996.
11. Chen ME, Troncoso P, Johnston DA, et al: Optimization of prostate biopsy strategy using computer based analysis. J Urol 158: 2168-2175, 1997.
12. Terris MK, and Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 145: 984-987, 1991.
13. Schmid HP, McNeal JE, Redwine EA, et al: Systematic morphometry of radical prostatectomy samples. A guideline for general practice. Helv Chir Acta 59: 471-476, 1992.
14. Schmid HP, and McNeal JE: An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16: 184-191, 1992.
15. Eskew LA, Bare RL, and McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157: 199-202, 1997.
16. Nava L, Montorsi F, and Consonni P: Results of a prospective randomized study comparing 6, 12, and 18 transrectal ultrasound guided sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultrasound. J Urol 157: 64A, 1997.
17. Saloman L, Colombel M, Patard JJ, et al: Use of three additional mid biopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy. Eur Urol 34: 313-317, 1998.
18. Chang JJ, Shinohara K, Bhargava V, et al: Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160: 2111-2114, 1998.
19. Terris MK, Wallen E, and Stamey TA: Comparison of lateral versus midlobe systematic sextant biopsies in the detection of prostate cancer. Urol Internat 59: 239-242, 1997.
20. Lui PD, Terris MK, McNeal JE, et al: Indications for ultrasound-guided transition zone biopsies in the detection of prostate cancer. J Urol 153: 1000-1003, 1995.
21. Terris MK, Pham TQ, Issa MM, et al: Routine performance of transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies is not indicated. J Urol 157: 204-206, 1997.
22. Chang JJ, Shinohara K, Hovey RM, et al: Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection. Urology 52: 89-93, 1998.
23. Terris MK, Freiha FS, McNeal JE, et al: Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 146: 78-84, 1991.
24. Abbas F, Hochberg D, Civantos F, et al: Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 30: 322-326, 1996.
25. Wiley EL, Davidson P, McIntire DD, et al: Risk of concurrent prostate cancer in cystoprostatectomy specimens is related to volume of high-grade prostatic intraepithelial neoplasia. Urology 49: 692-696, 1997.
26. Chun TY: Coincidence of bladder and prostate cancer. J Urol 157: 65-67, 1997.
27. Sakr WA, Grignon DJ, Crissman JD, et al: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8: 439-443, 1994.
28. Coffield KS, Speights VA, Brawn PN, et al: Ultrasound detection of prostate cancer in postmortem specimens with histological correlation. J Urol 147: 822-826, 1992.
29. Stemmermann GN, Nomura AM, Chyou PH, et al: A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience. Cancer Epidemiol Biomarkers Prev 1: 189-193, 1992.
30. Tulinius H: Latent malignancies at autopsy: a little used source of information on cancer biology. IARC Sci Publ 112: 253-261, 1991.